- 0
- 0
- 约4.8万字
- 约 12页
- 2025-10-22 发布于北京
- 举报
24April2014
Americas/UnitedStates
EquityResearch
Biotechnology
TheMedicinesCompany(MDCO)
RatingNEUTRAL*
Price(24Apr14,US$)26.05EARNINGS
Targetprice(US$)28.00¹
52-weekpricerange40.39-24.02
Marketcap.(US$m)1,684.80StrongUSAngiomax;NewHospitalProduct
Enterprisevalue(US$m)1,499.94
*StockratingsarerelativetothecoverageuniverseineachAcquired;StillCautious
analystsoreachteamsrespectivesector.
¹Targetpriceisfor12months.WhilecommercialresultsforQ1wererelativelysolid–terthan
原创力文档

文档评论(0)